Researchers develop platform to identify cancer mutations that may be responsive to drug therapies
A link between new diabetes cases and COVID-19
8 February 2021Iran starts limited COVID vaccinations with Russian shots
9 February 2021Researchers develop platform to identify cancer mutations that may be responsive to drug therapies
A Cleveland Clinic-led team of researchers has developed a personalized genomic medicine platform that will help advance accelerate genomic medicine research and genome-informed drug discovery, according to new study results published recently in Genome Biology.
